INTRODUCTION
1993), and B cell help (Del Prete et al., 1994; Saha et al., 1996) . In contrast to the majority of the CD4-positive The ability of Epstein-Barr virus (EBV) to immortalize human T cell lines of tumor origin, CD4-bearing T-LCLs efficiently human B lymphocytes in vitro has been very are susceptible to highly productive infection with both useful in studies on B cell biology, cell transforming funclaboratory and primary strains of HIV-1 and HIV-2 (Nick tion of EBV, and lymphomagenesis (reviewed by Kieff et al., 1993) . Thus, HVS-immortalized T-LCLs mimic in and Liebowitz, 1990) . Until recently, no similarly efficient many respects normal T lymphocytes and they can be approach existed for the immortalization of human T lymused for studies of T cell biology and function in longphocytes. In 1992, Biesinger et al. (1992) demonstrated living clonal T cells. In the present work, we investigated that certain strains of HVS, which, like EBV, is a member whether such T cell clones can be used to resolve the of gamma Herpesviruses and which causes T cell controversial role of IFNg in HIV-1 infection in T cells. lymphomas in New World monkeys (Roizman et al. 1990) , Cytokines play important but complex roles in AIDS can infect and transform human T lymphocytes in vitro.
pathogenesis Barker et al., 1995 ; Like EBV-positive B-lymphoblastoid cell lines, HVS-im- Clerici and Shearer, 1994) . Progression to AIDS appears mortalized T lymphoblastoid cell lines (T-LCLs) carry lato correlate with a shift from Th1 to Th2 cytokines (e.g., tent virus and grow for extended periods of time without there is a decrease in IFNg), but the significance of these antigenic or mitogenic stimulation (Biesinger et al., 1992;  changes is not clear (Clerici and Shearer, 1994) . Cyto-Weber et al., 1993) . T-LCLs also maintain important T kines like TNFa induce HIV-1 expression in vitro (Poli et lymphocyte functions, including functional receptors for al., 1990; Tadmori et al., 1991) , while IFNa2 inhibits virus antigen, signal transduction through TCR, CD3, CD4, or production (Brinchman et al., 1991) . The Th1 cytokine IL-2 receptors (Broker et al., 1993; Del Prete et al., 1994;  IFNg has dichotomous effects on HIV-1 replication in Mitrucker et al., 1993; Saha et al., 1996; Weber et al., macrophages and T cells, the two main target cells for HIV-1 infection . While IFNg protects primary macrophages and monocytic cell lines
with several studies showing little or no effect (Yama-nated by R. C. Gallo and was propagated and titered by the reverse transcriptase (RT) activity in H9 cells as described moto et al., 1986; Hartshorn et al., 1987) . The inconsistent effects of IFNg on HIV-1 replication in T cells can be (Popovic et al., 1984) . attributed to the experimental systems used, which in HIV-1 infection most cases included unfractionated PBMC rather than isolated CD4-positive T lymphocytes. Other, more exten-Cells were infected by resuspending 2 1 10 5 cells/ml sively studied cytokines such as TNF-a regulate HIV-1 in 1 ml of cell-free supernatant from H9/HTLV-III B cells expression through both autocrine and paracrine pathcontaining 5 1 10 5 cpm of RT activity. The cells were ways (Poli et al., 1990; Tadmori et al., 1991; incubated for 2 hr at 37Њ, thoroughly washed, and resusal., 1995) , but the function of endogenous IFNg in HIV-1 pended in fresh medium at 2 1 10 5 cells/ml. For control, replication in T cells is unknown. In this work, we have cells were mock-infected with a filtered, cell-free superemployed HVS-immortalized T-LCLs as a means to adnatant from an uninfected H9 cell culture. Anti-cytokine dress these problems. First, we were able to clone Tor control (nonimmune) antisera were added at 5 mg/ml LCLs to ensure the uniformity of T cell populations studas indicated. Viable cells were counted by trypan blue ied. Second, to determine the role of endogenous IFNg exclusion and supernatants were collected at designated in HIV-1 replication, we have examined HIV-1 infection days postinfection (dpi) and stored at 070Њ for analysis in phenotypically similar T cell clones which differed in of HIV-1 and cytokine production. their expression of IFNg. We report that in this system of long-lived CD4-positive T cell clones, endogenous IFNg RT and p24 assays augments HIV-1 replication and facilitates cytolysis of RT assays were performed in triplicates as previously infected cells.
described (Willey et al., 1988) . In brief, 5-ml samples were added to 25 ml of a mixture containing poly(C), oligo(dG) MATERIALS AND METHODS (Pharmacia Biotech Inc., Piscataway, NJ), MgCl 2 , DTT, Cells and viruses NP-40, NaCl, H 2 O, and 32 P-labeled deoxyguanidine 5triphosphate (Amersham Corp., Arlington Heights, IL).
Establishment of HVS-immortalized CD4/ T cell clones
The mixture was incubated for 2 hr at 37Њ and 6-ml samhas been described (Saha et al., 1996) . Briefly, PBL were ples were blotted onto DE81 paper, air dried, washed isolated from freshly drawn blood from HIV-1-negative dothree times in 21 SSC, and two times in 95% ethanol. nors on Ficoll-Hypaque gradient (Sigma Chemicals, St.
The filters were dried under a heat lamp and counted in Louis, MO) and adherent cells were separated by incubation a Beckman LS scintillation counter. on plastic tissue culture plates for 2 hr. Nonadherent cells HIV-1 core antigen p24 was measured using HIV Ag were resuspended at 1 1 10 6 cells/ml in RPMI 1640 medium kit (Coulter, Hialeah, FL) according to the manufacturer's supplemented with 10% heat-inactivated fetal calf serum, 2 instructions. mM L-glutamine, penicillin (100 units/ml), and streptomycin (100 mg/ml) and infected with HVS at a multiplicity of infec-Analysis of mRNA tion of 0.1. Infected cells were cultured in bulk for 2-3 weeks until immortalization was evident and then cloned at 0.5-Cellular RNA was isolated using a modified SDS/phenol extraction method as described (Liu et al., 1994) . 1.0 cells/well in 96-well culture plates with irradiated allogeneic PBL (100,000/well). The two CD4/ T cell clones, Control or HIV-1-infected cells 3 days after infection were washed and lysed in SDS/EDTA/Proteinase K solution. CHCD4 and KRCD4, that have been studied most extensively in this report were derived from PBL of two different RNA was extracted by phenol followed by phenol/chloroform/isoamylalcohol, precipitated by ethanol, and dis-donors and were maintained in the absence of exogenous IL-2 for over 1 year. Other IFNg-producing CD4/ T cell solved in DEPC-treated water. cDNA was synthesized by incubating 2 mg of oligo dT-primed RNA, MuLV RT, and clones used in this study are MC2-5.4, MC2-11, MC3-1.2, and DECD4; they were similarly developed from two other 1 mM dNTP (Perkin-Elmer-Cetus, Norwalk, CT) in a final volume of 40 ml at 42Њ for 15 min followed by 5 min normal donors and maintained in IL-2 (20 units/ml) containing medium. Consistent with other reports (Biesinger et at 99Њ and 5 min at 4Њ. The cDNA served as a template for amplification of human IL-2, IL-4, IFNg, or HIV-1 env-al., 1992; Del Prete et al., 1994) , the transformed cells carried HVS genomes as determined by polymerase chain reaction specific sequences by PCR using commercially available primers (Clontech, Palo Alto, CA) and according to manu-(PCR) amplification of HVS DNA (not shown) and did not produce HVS as determined in a coculture assay (Berend facturer's instructions. The amplifications yielded DNA fragments of 305, 344, and 427 base pairs (bp) for IL-et al., 1993) . HVS, group C, strain 488-77, was kindly provided by R. C. Desrosiers (Harvard Medical School, Boston, 2, IL-4, and IFNg, respectively. Each RNA sample was subjected to the reverse transcription step with or without MA). The virus was propagated in owl monkey kidney cells and titered by plaque assay in these cells as described RT to control for cellular DNA contamination. Plasmids containing cytokine genes were used as positive controls (Berend et al., 1993) . HIV-1 strain HTLV-III B was kindly do- tested on appropriate cells (Saha et al., 1996) .
Characterization of HVS-immortalized T cell clones
The HVS-immortalized cells were characterized by sur- clones expressed CD4 and other surface markers typical for activated T lymphocytes, but not CD8 or CD20 (B cell marker). Notably, CHCD4 but not KRCD4 expressed the in each amplification. Each sample also included primers T cell receptor Vb 2 chain, indicating that HVS does not for human b-actin gene (Clontech) as internal control for selectively immortalize T cells carrying a specific rethe presence of cellular RNA. b-actin amplicon was 838 arranged TCR-Vb chain, consistent with our previous bp. The primers used were designed to span introns to data (Saha et al., 1996) . Previous studies indicated that minimize detection of genomic DNA (Clontech). HIV-1 HVS-immortalized human CD4-positive T-LCLs ex-RNA was detected using primers BRUV3 and BRUV5, pressed predominantly IFNg, a Th1 cytokine, but not ILwhich span the V3 loop of HIV-1 and yield a 350-bp DNA 4, a Th2 cytokine (DeCarli et al., 1993; Saha et al., 1996) . fragment (Wain-Hobson et al., 1991) . All PCR amplifica-We tested CHCD4 and KRCD4 cells for the expression tions were carried out using 0.2 mM of dNTP and 0.4 of IL-2, IL-4, and IFNg at the protein and mRNA levels. mM of each primer and 32 cycles of 45 sec at 94Њ, 45
Significant levels of IFNg were detected in the supernasec at 60Њ, and 2 min at 72Њ, followed by one cycle at tants of CHCD4 but not KRCD4 cells (Table 2) . High level 72Њ for 7 min to permit completion of polymerization of production of IFNg was also detected in MC2-5.4, MC2the amplified products. The amplified products were re-11, MC3-1.2, and DECD4 clones used in this study and solved by electrophoresis on 1.8% agarose gels conin 20 other CD4/ T cell clones established in our laborataining ethidium bromide (0.5 g/ml). tory (not shown). Thus, KRCD4 is the only HVS-transformed CD4/ T cell clone described thus far which ex-Cytokine assays hibits IFNg-negative phenotype. Stimulation of CHCD4 Culture supernatants from uninfected or HIV-1-infected cells (TCR-Vb2) with TSST (a Vb2-specific superantigen) cells were collected at 3 days after infection and were resulted in increased IFNg levels, indicating that the sigstored in aliquots at 070Њ. Levels of IL-4 and IFNg were measured by ELISA using commercial kits for human Sciences, Cambridge, MA). tion of CHCD4 and KRCD4 cells early after infection, but to different levels (Fig. 3) . Consistent with a previous report (Nick et al., 1993) , HIV-1 infection in these cells was cytopathic and most of the cells in both systems died a short time after reaching peak HIV-1 production (Fig. 3) .
To test whether HIV-1 infection affected cytokine expression in CHCD4 and KRCD4 cells, total cellular RNA was isolated from infected cells 3 days after infection and the expression and relative levels of mRNA for IL-2, IL-4, and IFNg were tested by RT-PCR with uninfected cells serving as controls (Fig. 1) . The KRCD4 cells remained negative for background levels (Table 2 ) and no IL-2 or IL-4 mRNA was detected by RT-PCR (not shown). These results indicate that HIV-1 infection enhances the transcription and production of nal transduction pathway through TCR remains func-IFNg in CHCD4 cells; however, the increased levels of the tional (Saha et al., 1996) . However, as reported previously endogenous and secreted cytokine appear to have no inhibi- (Saha et al., 1996) , none of these clones showed evitory effect on HIV-1 replication in these cells. dence of either constitutive (Table 2) or inducible (not shown) production of IL-2 or IL-4. Assay of cytokine Effects of neutralization of IFNg mRNA production gave similar results to assay of protein production (Fig. 1) .
CHCD4 (lane 2) but not KRCD4 (lane
To determine whether endogenous IFNg plays any 4) cells constitutively produced IFNg mRNA, indicating role in HIV-1 infection in CHCD4 cells, we tested whether that the absence of IFNg in KRCD4 supernatants (Table  neutralizing antibodies against the cytokine modulate the 2) was due to a block of IFNg gene transcription rather course of HIV-1 replication in these cells. The IFNg-negathan to defective secretion of the cytokine by these cells.
tive KRCD4 cells served as controls in these experi-Neither clone constitutively expressed IL-2 or IL-4 mRNA ments. CHCD4 and KRCD4 cells were infected with HIVdetectable by RT-PCR and expression was not induced 1, cultured in the presence of neutralizing anti-IFNg or by PHA stimulation (data not shown). Thus, KRCD4 and control antibodies, and virus production was determined CHCD4 have many common characteristics of HVSby monitoring the RT activity in culture supernatants (Fig.  transformed CD4 -positive T cells, except that CHCD4 2B). The presence of anti-IFNg antibodies had no effect cells like most HVS-transformed T cells express endogeon HIV-1 replication in KRCD4 cells. In contrast, addition nous IFNg and KRCD4 cells do not. of these antibodies significantly inhibited virus replication in CHCD4 cells, particularly early after infection ( Fig.  HIV-1 
infection and effect on cytokine expression
2B). We have previously shown that polyclonal anti-IFNg antibodies could effectively neutralize endogenously pro-HVS-transformed T cells are highly permissive to HIV-1 (Nick et al., 1993) . We tested whether the observed differ-duced IFNg from HVS-transformed T cells (Saha et al., 1996) . The anti-IFNg at the dose used completely neutral-ences in IFNg expression by KRCD4 and CHCD4 cell lines affect their susceptibility to a laboratory strain HTLV-III B ized IFNg present in culture supernatants of uninfected CHCD4 cells; no IFNg was detected in these cultures (Figs. 1-3) . HIV-1 efficiently replicated in both KRCD4 and CHCD4 cells but virus infection was faster and production during initial 5-6 days, but cytokine levels gradually increased thereafter (data not shown). Addition of fresh was higher in CHCD4 cells compared to KRCD4 cells ( Fig.  2A) . This may be because CHCD4 cells grew faster than anti-IFNg antibodies to HIV-1-infected CHCD4 cells at 4to 5-day intervals did not significantly change the pattern KRCD4 cells (Fig. 3) . However, as determined by RT-PCR for HIV-1 V3-loop-specific mRNA, both cells expressed viral of HIV-1 replication obtained upon single anti-IFNg treatment (data not shown) as other factors are also likely to envelope-encoding mRNA 3 days after infection (Fig. 1,  lanes 16 and 17) . Exposure to HIV-1 enhanced the prolifera-be involved in HIV-1 infection of these cells. Presence of HIV-1 INFECTION OF HVS CD4-POSITIVE T CELLS   FIG. 2. Infection of IFNg-producing (CHCD4) and IFNg-negative (KRCD4) cells by HIV-1 (A) and effects of anti-IFNg antibodies on HIV-1 production (B). Cells were infected with HIV-1 and cultured in the presence or absence of anti-IFNg or control antibodies as described under Materials and Methods. Virus production was monitored by supernatant reverse transcriptase (RT) assay at the times indicated.
anti-IFNg antibodies also significantly reduced the cyto-( Fig. 2B) and most of the cells eventually died, similar to infected cells cultured in the absence of the antibody pathic effects of HIV-1 infection in CHCD4 cells but had little or no effect on viability of infected KRCD4 cells (Fig.  (Fig. 3) . Treatment of uninfected CHCD4 cells with anti-IFNg antibodies did not affect cell viability or growth rate 3). In spite of the initial reduction in virus production, HIV-1-infected CHCD4 cells cultured in the presence of as determined by trypan blue exclusion or [ 3 H]thymidine incorporation methods, respectively (data not shown), in-anti-IFNg continued to produce HIV-1 at lower levels caution in using IFNg for control of HIV-1 infection in patients.
The studies reported here have been made possible by the recent development of the efficient method of human T lymphocytes immortalization by HVS (reviewed by Meinl et al., 1995) . HVS-immortalized CD4-positive T lymphocytes maintain normal T cell functions, including their susceptibility to efficient HIV-1 infection (Nick et al., 1993) . Although the majority of the HVS-immortalized T cell clones described thus far exhibit the Th1 profile, including IFNg expression (De Carli et al., 1993; Saha et al., 1996) , we have identified one T cell clone, KRCD4, which does not express IFNg (Table 1) . Comparison of the KRCD4 cells with the phenotypically similar but IFNgproducing CD4/ T cell clones permitted us to determine the role of endogenous IFNg in HIV-1 replication in this model system. Three conclusions can be drawn from these studies: tion of macrophages (Fan et al., 1994) , endogenous IFNg Cells were infected as described in the legend to Fig. 2 and cell viability does not inhibit HIV-1 infection and virus-mediated cytolwas determined by trypan blue exclusion at the times indicated. ysis in cloned immortalized T lymphocytes. In fact, HIV-1 replicated faster and to higher levels in IFNg-positive dicating that inhibitory effect of the antibody on virus CHCD4 cells than in IFNg-negative KRCD4 cells (Fig. 2) , production is not due to antibody effects on target cell physiology. The inhibitory effects of anti-IFNg antibodies on HIV-1 replication were surprising in that they contradict the postulated role of this cytokine in controlling HIV-1 infection in T cells (Wong et al., 1988) . To confirm this phenomenon, we tested the effect of anti-IFNg antibodies on HIV-1 replication in four other HVS-immortalized T cell clones which constitutively express IFNg at the levels comparable to that of CHCD4 cells (not shown). As shown in Fig. 4 , neutralization of IFNg significantly inhibited HIV-1 production in a range of 37-56% in all four CD4/ T cell clones. Like CHCD4 cells, although HIV-1 production in these clones was not completely arrested after anti-IFNg treatments, rate of virus replication ( Fig. 4) and virus-induced cytolysis (data not shown) were significantly inhibited. Together, these results demonstrate that not only does endogenous IFNg fail to inhibit HIV-1 infection in HVS-immortalized CD4/ T cells, but that it can significantly enhance virus replication and its cytopathic effects in these cells.
DISCUSSION
The role of IFNg in HIV-1 infection of T cells is controversial . Using phenotypically FIG. 4 . Inhibition of HIV-1 production in HVS-immortalized CD4/ T cell clones by anti-IFNg antibodies. Cells were infected with HIV-1 as similar HVS-immortalized T cell clones that differ in described for the experiment described in the legend of Fig. 2 . Antitheir expression of IFNg, we demonstrate here that IFNg or control antibodies (5 mg/ml) were added to each clone as endogenous IFNg does not inhibit HIV-1 infection in indicated. Culture supernatants were collected after 7 days and as-T cells. To the contrary, our data suggest that endogesayed for HIV-p24 production. Percentage inhibition by anti-IFNg antinous IFNg enhances HIV-1 replication and virus-medibodies was calculated in respect to virus production in the presence of control antibodies.
ated cytolysis in this model. These results recommend although this difference could also be attributed to the cells in vivo. The upregulation of IFNg production by HIV-1 may contribute to HIV-1 pathogenesis in vivo in several observed variability among HVS-immortalized T cells in HIV-1 replication (Nick et al., 1993) . Other HVS-immortal-ways, including enhancement of T cell apoptosis , Groux et al., 1992 Clerici et al., 1994) , enhanced ized CD4-positive T cell lines we established from PBL of normal donors (Saha et al., 1996) which constitutively T cell death through stimulation of HIV-1 replication (Fig.  3 ), or deleterious effects in cellular gene expression express IFNg are also susceptible to efficient HIV-1 infection (data not shown). The lack of antiviral activity of (Balkwill and Burke, 1989; Atwood et al., 1994) . IFNg may also cause harmful effects indirectly, as proposed for IFNg in T lymphocytes observed here is consistent with the study of Brinchmann et al. (1991) and Kinter et al. brain injury in AIDS through activation of brain macrophages (Gendelman et al., 1994) . Although HVS-immor-(1995) but contradicts the results of Wong et al. (1988) , who showed that exogenous IFNg alone or in combina-talized T cells do not exactly represent primary T cells and we cannot completely rule out the possibility that tion with TNF-a inhibited HIV-1 production in T cell lines and primary T cells. One explanation of these discrepan-other HVS-specific or cellular genes differentially expressed in these cells influenced HIV-1 infection, our cies is the use of unfractionated PBMC in the cited studies, a problem which has been alleviated here by em-results here demonstrate that at least in this system, production of endogenous IFNg by CD4/ T cells en-ploying immortalized T cell clones differing primarily in the expression of secretable IFNg. These results indicate hances HIV-1 replication.
In conclusion, our results add to the complex picture that the anti-HIV-1 activity of IFNg is target cell dependent; the cytokine efficiently blocks HIV-1 infection of of the roles of IFNg and other cytokines in HIV-1 infection. IFNg augments anti-viral activities of cytotoxic cells macrophages but has no such effect in T lymphocytes.
(ii) Surprisingly, instead of virus inhibition, endoge- (Lolli et al., 1994; and protects monocyte/ macrophages against HIV infection (Gendelman et al., nous IFNg-enhanced HIV-1 replication in our clones. Neutralization of IFNg produced by CHCD4 cells (Fig.  1990 ). However, IFNg enhances HIV-1 replication in CD4-positive T cells (Kinter et al., 1995, and this work) . 2B) and other CD4-positive clones (Fig. 4) significantly reduced virus production. As expected, anti-IFNg anti-
The contradictory roles of IFNg in HIV-1 infection in different cell types may explain the lack of success in one bodies had no effect on HIV-1 production in the cytokinenegative KRCD4 cells (Fig. 2B) . The mechanism of HIV-clinical trial of this cytokine in AIDS patients (Agosti et al., 1992) . Another study reported rapid exacerbation of 1 enhancement by IFNg is unknown, but it may involve some of the regulatory effects of interferon on the expres-Kaposi's sarcoma in an AIDS patient on IFNg therapy and the authors recommended caution in using IFNg in sion of cellular genes (Samuel, 1991) or augmentation of HIV-1 gp41 binding to cell surface, as shown using BJAB HIV-1-infected patients (Albrecht et al., 1994) . The system described here will permit detailed studies on the inter-cell line (Chen et al., 1993) . Since HIV-1 replication invariably results in cytolysis of primary T lymphocytes (Fauci, action between IFNg and HIV-1 in T lymphocytes with the aim of uncoupling their reciprocal stimulation of ex-1993), our results also indicate that endogenous IFNg may be responsible for enhanced lysis of CD4-positive pression.
